The ACR has developed new guidance for rheumatology providers on the use of the COVID-19 vaccines for patients with rheumatic and musculoskeletal diseases (RMDs). The recommendations focus on general considerations related to COVID-19 vaccination in RMD patients, disease- and timing-related considerations for specific patient groups, and timing considerations for vaccine administration and immunomodulatory medications.
All recommendations are based on current knowledge and will be revised as circumstances and evidence evolve.
COVID-19 Vaccine Clinical Guidance Town Hall
The ACR is hosting a town hall on COVID-19 vaccine clinical guidance on Feb. 16, from 7:30–8:30 p.m. ET. Attendance is complimentary, but registration is required. Attendees can submit questions in advance that may be answered during the town hall.